JP2025511151A5 - - Google Patents
Info
- Publication number
- JP2025511151A5 JP2025511151A5 JP2024557967A JP2024557967A JP2025511151A5 JP 2025511151 A5 JP2025511151 A5 JP 2025511151A5 JP 2024557967 A JP2024557967 A JP 2024557967A JP 2024557967 A JP2024557967 A JP 2024557967A JP 2025511151 A5 JP2025511151 A5 JP 2025511151A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nanobody
- cdr1
- cdr2
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210331478.7 | 2022-03-30 | ||
| CN202210331478.7A CN114685662B (zh) | 2022-03-30 | 2022-03-30 | 抗cd7纳米抗体、衍生物及其在肿瘤治疗中的应用 |
| PCT/CN2022/136785 WO2023185072A1 (zh) | 2022-03-30 | 2022-12-06 | 抗cd7纳米抗体、衍生物及其在肿瘤治疗中的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511151A JP2025511151A (ja) | 2025-04-15 |
| JP2025511151A5 true JP2025511151A5 (https=) | 2025-12-15 |
Family
ID=82140224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557967A Pending JP2025511151A (ja) | 2022-03-30 | 2022-12-06 | 抗ｃｄ７ナノボディおよびその派生物ならびに腫瘍治療におけるその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250352579A1 (https=) |
| EP (1) | EP4501962A4 (https=) |
| JP (1) | JP2025511151A (https=) |
| KR (1) | KR20240163684A (https=) |
| CN (4) | CN115806618B (https=) |
| AU (1) | AU2022449781A1 (https=) |
| CA (1) | CA3247190A1 (https=) |
| WO (1) | WO2023185072A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115806618B (zh) * | 2022-03-30 | 2025-11-11 | 河北森朗生物科技有限公司 | 一种抗cd7的纳米抗体vhh12及其相关产品、方法和用途 |
| CN115991776B (zh) * | 2022-10-26 | 2023-08-01 | 上海驯鹿生物技术有限公司 | 一种靶向cd7的全人源抗体及其应用 |
| CN117362437A (zh) * | 2023-07-21 | 2024-01-09 | 南京蓬勃生物科技有限公司 | 靶向人源cd7的抗体或其抗原结合片段及其应用 |
| CN116970082B (zh) * | 2023-09-22 | 2023-12-12 | 汇智生物技术(苏州)有限公司 | 人源cd7单克隆抗体及其制备方法和应用 |
| CN119285780B (zh) * | 2023-11-20 | 2026-04-07 | 上海百英生物科技股份有限公司 | 一种抗cd28纳米抗体及其制备方法与应用 |
| CN117843787B (zh) * | 2023-12-29 | 2026-03-31 | 华道(上海)生物医药股份有限公司 | 一种抗cd7抗体及其应用 |
| CN117946272A (zh) * | 2023-12-29 | 2024-04-30 | 华道(上海)生物医药有限公司 | 一种靶向cd7的抗体及其应用 |
| CN118580353B (zh) * | 2024-06-12 | 2025-03-28 | 深圳厚朴医疗健康科技有限公司 | 一种靶向b7-h3的单域抗体、嵌合抗原受体分子、嵌合抗原受体细胞及其在制备治疗鼻咽癌的药物中的应用 |
| WO2026007830A1 (zh) * | 2024-07-03 | 2026-01-08 | 深圳市济因生物科技有限公司 | 一种靶向cd7的纳米抗体及其应用 |
| CN119215156B (zh) * | 2024-12-05 | 2025-05-13 | 山东省成体细胞产业技术研究院有限公司 | 一种体内生成car-t的纳米颗粒及其应用 |
| CN119978135B (zh) * | 2025-01-02 | 2025-11-21 | 生物岛实验室 | Sumo标签蛋白的特异性抗体及其制备方法与应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4957735A (en) | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| US4902505A (en) | 1986-07-30 | 1990-02-20 | Alkermes | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5004697A (en) | 1987-08-17 | 1991-04-02 | Univ. Of Ca | Cationized antibodies for delivery through the blood-brain barrier |
| US5055303A (en) | 1989-01-31 | 1991-10-08 | Kv Pharmaceutical Company | Solid controlled release bioadherent emulsions |
| US5271961A (en) | 1989-11-06 | 1993-12-21 | Alkermes Controlled Therapeutics, Inc. | Method for producing protein microspheres |
| US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
| US5268164A (en) | 1990-04-23 | 1993-12-07 | Alkermes, Inc. | Increasing blood-brain barrier permeability with permeabilizer peptides |
| US5254342A (en) | 1991-09-30 | 1993-10-19 | University Of Southern California | Compositions and methods for enhanced transepithelial and transendothelial transport or active agents |
| DE69311538D1 (de) | 1992-03-12 | 1997-07-17 | Alkermes Inc | Acth enthaltende mikrokugeln mit gesteuerter abgabe |
| US5534496A (en) | 1992-07-07 | 1996-07-09 | University Of Southern California | Methods and compositions to enhance epithelial drug transport |
| US5514670A (en) | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
| CN104004095B (zh) * | 2014-06-04 | 2016-11-23 | 博生吉医药科技(苏州)有限公司 | 一种cd7纳米抗体、其编码序列及应用 |
| CA2972714A1 (en) * | 2014-09-09 | 2016-03-17 | Unum Therapeutics | Chimeric receptors and uses thereof in immune therapy |
| JP7237449B2 (ja) * | 2015-02-27 | 2023-03-13 | アイセル・ジーン・セラピューティクス・エルエルシー | 血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法 |
| MA51428A (fr) * | 2017-12-22 | 2020-11-04 | Bluebird Bio Inc | Récepteur d'antigène chimérique multivalent |
| CN109652379B (zh) * | 2018-12-29 | 2022-08-16 | 博生吉医药科技(苏州)有限公司 | Cd7嵌合抗原受体修饰的nk-92mi细胞及其应用 |
| CN115925976A (zh) * | 2019-11-21 | 2023-04-07 | 博生吉医药科技(苏州)有限公司 | Cd7-car-t细胞及其制备和应用 |
| CN113234682B (zh) * | 2021-01-12 | 2023-02-21 | 上海雅科生物科技有限公司 | 靶向cd7的工程化免疫细胞、嵌合抗原受体、cd7阻断分子及应用 |
| CN113402619B (zh) * | 2021-06-30 | 2022-03-22 | 徐州医科大学 | 一种靶向B7H3共表达IL-21的全人源嵌合抗原受体、iNKT细胞及其用途 |
| CN115806618B (zh) * | 2022-03-30 | 2025-11-11 | 河北森朗生物科技有限公司 | 一种抗cd7的纳米抗体vhh12及其相关产品、方法和用途 |
-
2022
- 2022-03-30 CN CN202211553986.6A patent/CN115806618B/zh active Active
- 2022-03-30 CN CN202510164231.4A patent/CN120005024A/zh active Pending
- 2022-03-30 CN CN202210331478.7A patent/CN114685662B/zh active Active
- 2022-03-30 CN CN202211553987.0A patent/CN116715766B/zh active Active
- 2022-12-06 AU AU2022449781A patent/AU2022449781A1/en active Pending
- 2022-12-06 JP JP2024557967A patent/JP2025511151A/ja active Pending
- 2022-12-06 US US18/852,462 patent/US20250352579A1/en active Pending
- 2022-12-06 CA CA3247190A patent/CA3247190A1/en active Pending
- 2022-12-06 WO PCT/CN2022/136785 patent/WO2023185072A1/zh not_active Ceased
- 2022-12-06 KR KR1020247034123A patent/KR20240163684A/ko active Pending
- 2022-12-06 EP EP22934890.9A patent/EP4501962A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025511151A5 (https=) | ||
| US20240066122A1 (en) | Methods and compositions for adoptive cell therapy | |
| CN112969713B (zh) | 结合结构域 | |
| US10093746B2 (en) | Glypican-3 antibody and uses thereof | |
| AU2016297014B2 (en) | Methods for improving the efficacy and expansion of immune cells | |
| JP2023036657A (ja) | 修飾されたｔ細胞及びその使用方法 | |
| EP3664820B1 (en) | Methods for producing genetically engineered cell compositions and related compositions | |
| JP2025143407A (ja) | キメラ受容体及びその使用方法 | |
| JP2025511151A (ja) | 抗ｃｄ７ナノボディおよびその派生物ならびに腫瘍治療におけるその使用 | |
| US20210277120A1 (en) | Compositions and methods for treatment of t cell malignancies | |
| US20220177524A1 (en) | Nef-containing t cells and methods of producing thereof | |
| CN115052902A (zh) | 淋巴细胞-抗原提呈细胞共刺激因子及其应用 | |
| US20220289814A1 (en) | Engineered t cells and methods of producing thereof | |
| KR20230084470A (ko) | 면역 세포 기능의 향상 | |
| TW202309091A (zh) | 嵌合受體及其使用方法 | |
| TW202237633A (zh) | 嵌合受體及其使用方法 | |
| US20240067737A1 (en) | Humanized Anti-GDNF family alpha-receptor 4 (GRF-alpha-4) Antibodies and Chimeric Antigen Receptors (CARs) | |
| CN114539423B (zh) | 一种三特异性融合蛋白及其用途 | |
| TWI915404B (zh) | 用於治療ｅｇｆｒ陽性癌症之組合物及方法 | |
| RU2829934C2 (ru) | Связывающий домен | |
| CN121780440A (zh) | 免疫细胞治疗 | |
| EA050762B1 (ru) | Аллогенные терапевтические клетки | |
| HK40045337A (en) | Methods and compositions for adoptive cell therapy | |
| HK40026612A (en) | Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy | |
| HK1244826B (en) | Methods and compositions for adoptive cell therapy |